So‐mi Kang

599 total citations
22 papers, 313 citations indexed

About

So‐mi Kang is a scholar working on Molecular Biology, Cell Biology and Neurology. According to data from OpenAlex, So‐mi Kang has authored 22 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Neurology. Recurrent topics in So‐mi Kang's work include Nuclear Structure and Function (16 papers), RNA Research and Splicing (10 papers) and DNA Repair Mechanisms (4 papers). So‐mi Kang is often cited by papers focused on Nuclear Structure and Function (16 papers), RNA Research and Splicing (10 papers) and DNA Repair Mechanisms (4 papers). So‐mi Kang collaborates with scholars based in South Korea, Switzerland and Ethiopia. So‐mi Kang's co-authors include Bum-Joon Park, Nam‐Chul Ha, Jinsook Ahn, Inseong Jo, Ah‐Young Oh, So‐Young Park, Yong‐Hak Kim, Suhyeon Kim, Jung-Hyun Cho and Su Jin Lee and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

So‐mi Kang

21 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
So‐mi Kang South Korea	11	267	76	26	18	15	22	313
Pauline Adjibade Canada	8	280 1.0×	93 1.2×	19 0.7×	5 0.3×	15 1.0×	20	323
Aurélie Barbet France	5	161 0.6×	43 0.6×	16 0.6×	12 0.7×	7 0.5×	6	195
Finja Büchel Germany	7	222 0.8×	36 0.5×	12 0.5×	12 0.7×	20 1.3×	7	267
Steven Rodriguez United States	7	119 0.4×	99 1.3×	21 0.8×	15 0.8×	22 1.5×	7	239
Zhenxing Zhong China	8	123 0.5×	169 2.2×	22 0.8×	8 0.4×	13 0.9×	14	275
Zhaofeng Gao China	9	373 1.4×	24 0.3×	27 1.0×	11 0.6×	14 0.9×	16	437
Audrey W. Hong United States	3	233 0.9×	285 3.8×	40 1.5×	8 0.4×	19 1.3×	5	399
Giora Volpert Israel	8	244 0.9×	53 0.7×	16 0.6×	6 0.3×	30 2.0×	8	287
J. Anthony Graves United States	7	281 1.1×	43 0.6×	28 1.1×	17 0.9×	18 1.2×	7	335

Countries citing papers authored by So‐mi Kang

Since Specialization

Citations

This map shows the geographic impact of So‐mi Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by So‐mi Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites So‐mi Kang more than expected).

Fields of papers citing papers by So‐mi Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by So‐mi Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by So‐mi Kang. The network helps show where So‐mi Kang may publish in the future.

Co-authorship network of co-authors of So‐mi Kang

This figure shows the co-authorship network connecting the top 25 collaborators of So‐mi Kang. A scholar is included among the top collaborators of So‐mi Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with So‐mi Kang. So‐mi Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Soyoung, Ah‐Young Oh, Yun‐Jeong Shin, et al.. (2024). The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression. SHILAP Revista de lepidopterología. 32(4). 200875–200875.

Kim, Bae-Hoon, Yeon‐Ho Chung, So‐mi Kang, et al.. (2024). NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues. International Journal of Molecular Sciences. 25(12). 6558–6558. 1 indexed citations

Kang, So‐mi, Seungwoon Seo, Eun Ju Song, et al.. (2023). Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson–Gilford Progeria Syndrome. Cells. 12(9). 1232–1232. 7 indexed citations

Kim, Bae-Hoon, et al.. (2023). Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS. Cells. 12(18). 2299–2299. 2 indexed citations

Ahn, Jinsook, et al.. (2022). Crystal structure of progeria mutant S143F lamin A/C reveals increased hydrophobicity driving nuclear deformation. Communications Biology. 5(1). 267–267. 5 indexed citations

Ahn, Jinsook, Inseong Jo, So‐mi Kang, et al.. (2022). Cyclin-dependent kinase 1 depolymerizes nuclear lamin filaments by disrupting the head-to-tail interaction of the lamin central rod domain. Journal of Biological Chemistry. 298(9). 102256–102256. 11 indexed citations

Ahn, Jinsook, Jinwook Lee, Inseong Jo, et al.. (2022). Structural basis for the interaction between unfarnesylated progerin and the Ig-like domain of lamin A/C in premature aging disorders. Biochemical and Biophysical Research Communications. 637. 210–217. 3 indexed citations

Kang, So‐mi, So‐Young Park, Jung-Hyun Cho, et al.. (2021). Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model. Communications Biology. 4(1). 1397–1397. 11 indexed citations

Kang, So‐mi, Jinsook Ahn, Sang Ah Yi, et al.. (2021). Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A. Scientific Reports. 11(1). 17776–17776. 1 indexed citations

10.

Ahn, Jinsook, et al.. (2021). Beta-strand-mediated dimeric formation of the Ig-like domains of human lamin A/C and B1. Biochemical and Biophysical Research Communications. 550. 191–196. 10 indexed citations

11.

Kang, So‐mi, Jinsook Ahn, Ji-Eun Kim, et al.. (2021). Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome. Communications Biology. 4(1). 5–5. 27 indexed citations

12.

Kang, So‐mi, Jinsook Ahn, Sang Ah Yi, et al.. (2021). Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A. Scientific Reports. 11(1). 9122–9122. 5 indexed citations

13.

Kang, So‐mi, Jinsook Ahn, Ji-Eun Kim, et al.. (2021). Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome. Communications Biology. 4(1). 297–297. 2 indexed citations

14.

Ahn, Jinsook, So‐mi Kang, Inseong Jo, et al.. (2021). The flavonoid morin alleviates nuclear deformation in aged cells by disrupting progerin-lamin A/C binding. Journal of Functional Foods. 77. 104331–104331. 3 indexed citations

15.

Ahn, Jinsook, et al.. (2020). Separation of Coiled-Coil Structures in Lamin A/C Is Required for the Elongation of the Filament. Cells. 10(1). 55–55. 19 indexed citations

16.

Kang, So‐mi, Su Jin Lee, Ah‐Young Oh, et al.. (2019). p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation. Cell Death and Disease. 10(2). 107–107. 36 indexed citations

17.

Ahn, Jinsook, Inseong Jo, So‐mi Kang, et al.. (2019). Structural basis for lamin assembly at the molecular level. Nature Communications. 10(1). 3757–3757. 71 indexed citations

18.

Cho, Jung-Hyun, Ah‐Young Oh, So‐Young Park, et al.. (2018). Loss of NF2 Induces TGFβ Receptor 1–mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome. Molecular Cancer Therapeutics. 17(11). 2271–2284. 15 indexed citations

19.

Park, So‐Young, Ah‐Young Oh, Jung-Hyun Cho, et al.. (2018). Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant Cancers. Molecular Cancer Research. 16(6). 935–946. 13 indexed citations

20.

Cho, Jung-Hyun, Jeehyun Lee, Youn‐Sang Jung, et al.. (2016). Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification. Oncotarget. 7(23). 35144–35158. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact